Skip to main content
. 2019 Jun 12;10:108. doi: 10.4103/ijpvm.IJPVM_14_18

Table 4.

Therapeutic protocols in 658 patients with brucellosis in Kohgilouyeh and Boyerahmad province, Southwest of Iran

Therapeutic combinations Percentage n=658 n (%) Duration (weeks)
Doxycycline + rifampin 183 (27.8) 2-8
Doxycycline + streptomycin 84 (13.1) 1-8
Doxycycline + streptomycin + rifampin 54 (8.2) 2-8
Gentamicin + cotrimoxazole 49 (7.4) 2-8
Gentamicin 32 (4.9) 1-2
Cotrimoxazole + rifampin 28 (4.3) 2-8
Rifampin 23 (3.5) 2-8
Doxycycline + gentamicin + rifampin 21 (3.2) 2-8
Tetracycline + rifampin 17 (2.6) 2-8
Gentamicin + rifampin 16 (2.4) 1-4
Streptomycin 12 (1.8) 1-3
Streptomycin + rifampin 10 (1.5) 3-8
Others 129 (19.3) 1-8